The expression of p-Akt, p-mTOR, and p-4EBP1 was significantly higher in WT HCC compared to L-ChREBP-KO mice, suggesting a link between ChREBP activity and the AKT/mTOR pathway (Figure 8). The gene discussed is AKT1; the disease is hepatocellular carcinoma.